The joint symposium run by EHA and ESH
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
EBMT Nurses Group: who we are and what we aim to achieve
Oral azacitidine maintenance therapy for post-transplant AML
Azacitidine/HDAC inhibitor combination for high risk AML: a promising pilot study